Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities by James Tumlin, Brad Rovin, Hans-Joachim Anders, Eduardo F. Mysler, David R.W. Jayne, Tsutomu Takeuchi, Catharina Lindholm, Gudrun Weiss, Alessandro Sorrentino, Kevin Woollard, Nicola Ferrari

Get full text